SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

Eli Lilly bowel disease treatment succeeds in late-stage study

· 03/16/2021 06:55
Eli Lilly bowel disease treatment succeeds in late-stage study

- Eli Lilly and Co LLY.N said on Tuesday its experimental treatment for an inflammatory bowel disease succeeded in a late-stage trial.

The drug, mirikizumab, met the main goal of showing reduced bowel urgency in moderate to severe ulcerative colitis.


(Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)

((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 8325;))